Primel reveals positive results for Active Hand Coating to combat hospital-acquired infections

Pallavi Madhiraju- April 7, 2024 0

Primel, a pioneer in the realm of infection prevention solutions, has announced remarkable results from a recent study, confirming the superior sporicidal activity of its ... Read More

Bristol Myers Squibb announces success of KRAZATI in Phase 3 KRYSTAL-12 study

Pallavi Madhiraju- April 1, 2024 0

Bristol Myers Squibb (NYSE: BMY) has reached a pivotal milestone in the treatment of non-small cell lung cancer (NSCLC) with its announcement regarding the KRYSTAL-12 ... Read More

MPOWERHealth acquires Assure Neuromonitoring operations to enhance intraoperative care

Pallavi Madhiraju- March 30, 2024 0

MPOWERHealth, a leading innovator in the field of intraoperative neuromonitoring (IONM), has made a significant move to expand its services through the strategic acquisition of ... Read More

AstraZeneca to acquire Fusion Pharmaceuticals to boost cancer radioconjugate development

Pallavi Madhiraju- March 19, 2024 0

In a strategic move to revolutionize cancer treatment, AstraZeneca has announced its definitive agreement to acquire Fusion Pharmaceuticals Inc., a pioneer in the development of ... Read More

Lunit announces strategic partnerships to advance AI in cancer diagnostics across Europe

Pallavi Madhiraju- March 19, 2024 0

Lunit (KRX:328130.KQ), a frontrunner in AI-powered solutions for cancer diagnostics and therapeutics, is marking a significant milestone in its expansion across Europe through two pivotal ... Read More

Kroger to offload specialty pharmacy business to CarelonRx in strategic shift in healthcare services

Pallavi Madhiraju- March 19, 2024 0

The Kroger Co. (NYSE: KR) has announced a definitive agreement for the sale of its specialty pharmacy business to CarelonRx, a subsidiary of Elevance Health, ... Read More

Microsoft and NVIDIA forge ahead with AI and cloud computing in healthcare

Pallavi Madhiraju- March 19, 2024 0

Microsoft Corp. is expanding its longstanding partnership with NVIDIA, setting a new benchmark in the integration of generative AI, cloud, and accelerated computing within the ... Read More

Bristol Myers Squibb and 2seventy bio’s Abecma gets positive FDA committee vote for multiple myeloma

Pallavi Madhiraju- March 18, 2024 0

In a significant development in the healthcare industry, Bristol Myers Squibb (NYSE: BMY) and 2seventy bio, Inc. (Nasdaq: TSVT) have announced a favorable vote by ... Read More

Zydus Lifesciences gains FDA aproval for Chlorpromazine Hydrochloride Injection

Pallavi Madhiraju- March 14, 2024 0

In a notable development for the pharmaceutical industry, Zydus Lifesciences Limited, along with its subsidiaries and affiliates, has received final approval from the United States ... Read More

Asep Medical adopts innovative AI approach to address antibiotic resistance

Pallavi Madhiraju- March 14, 2024 0

In a significant announcement at the US Biophysical Society in Philadelphia, Asep Medical Holdings Inc. (CSE: ASEP) (OTCQB: SEPSF) (FSE: JJ8) has shared a breakthrough ... Read More